Skip to content

NovoPen Echo

by Novo Nordisk, Inc.

510(k) K162602

NovoPen Echo is a medical device (FDA Class II; FDA product code FMF, Syringe, Piston) made by Novo Nordisk, Inc., cleared under FDA 510(k) K162602 on 18 Oct 2016, active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK162602 Date18 Oct 2016ClearedStatusActive

Official records

From the FDA record

Received by the FDA
19 Sep 2016
FDA decision
18 Oct 2016 (Substantially Equivalent)
FDA review time
29 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K162602 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-0206-2018 FDA Class II initiated 5 Jul 2017

    A small number of batches may crack or break if exposed to certain chemicals, like certain cleaning agents.

Timeline

2 dated events

  1. Cleared FDA 510(k) K162602
  2. Recall initiated FDA recalls Z-0206-2018

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
FMF
Device class
Class II
Regulation
21 CFR Part 880.5860
Advisory committee
General Hospital
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code FMF (Syringe, Piston).

Other devices from Novo Nordisk Inc.

See all devices from Novo Nordisk Inc. →